Baird

Splunk Inc (NASDAQ: SPLK) has strong underlying business fundamentals, reflected in its solid growth in annual recurring revenue (ARR), while the company has made strategic moves by investing in its cloud offering, according to Baird. The Splunk Analyst: Jonathan Ruykhaver upgraded Splunk to...

Retail executives face an uphill battle in succeeding in a turnaround plan but a bullish stance on Bed Bath & Beyond Inc. (NASDAQ: BBBY) is "worth a shot," according to Baird. The Analyst: Peter Benedict upgraded Bed Bath & Beyond's stock from Neutral to Outperform with a...

Illumina, Inc. (NASDAQ: ILMN) announced Monday a deal to buy privately held Grail, which focuses on early detection of multiple cancers, for $8 billion in cash and stock.  The Illumina Analysts: Baird analyst Catherine Ramsey Schulte maintained a Neutral rating on Illumina shares and lowered...

Beyond Meat Inc (NASDAQ: BYND) shares traded higher on Thursday after one Wall Street analyst initiated bullish coverage of the stock. The Beyond Meat Analyst: Baird analyst Ben Kallo initiated coverage of Beyond Meat with an Outperform rating and a $160 price target. The Beyond Meat Thesis: ...

Three analysts are increasing their Lululemon Athletica Inc (NASDAQ: LULU) price targets ahead of the retailer's second-quarter earnings report.  Piper Sandler also went into detail on Lululemon's acquisition of the fitness company Mirror.  The Lululemon Analysts: Wedbush analyst...

Specialty fashion retailer Urban Outfitters, Inc. (NASDAQ: URBN) reported second-quarter results Tuesday that were highlighted by a surprise profit, but two Street analysts are staying on the fence due to the stock's valuation.  The Urban Outfitters Analysts Baird analyst Mark...

Salesforce.com, inc. (NYSE: CRM) shares jumped 25% on Wednesday after the company reported blowout second-quarter earnings numbers and exceeded expectations with its full-year guidance. Salesforce reported second-quarter EPS of $1.44 on $5.15 billion in revenue. Both numbers exceeded consensus...

Tesla Inc (NASDAQ: TSLA) shares are up 6% on Wednesday after the company announced a 5-for-1 stock split on Tuesday afternoon. The stock split will be implemented after the market close Aug. 31. Companies with relatively high stock prices like Tesla often implement stock splits to bring...

In less than two decades, Tesla Inc (NASDAQ: TSLA) went from upstart to the most valuable car company in the world, turning mainstream electric vehicles from a thing of science fiction to reality. Tesla reports second-quarter earnings on Wednesday after the market closes. The EPS and sales numbers...

Although Amazon.com, Inc’s (NASDAQ: AMZN) stock has gained 63% year to date versus the S&P’s 3% decline, prospects of the company are still not completely priced in, according to Baird. The Amazon Analyst: Colin Sebastian maintained an Outperform rating for Amazon, while raising the...

Lululemon Athletica Inc (NASDAQ: LULU) shares gained 5.5% on Tuesday after the company announced a $500 million buyout of in-home fitness company Mirror. Mirror is Lululemon’s first major acquisition, and the deal is expected to close in the second half of the year. New Way To Connect Bank of...

Apple Inc. (NASDAQ: AAPL) kicked off its annual developer conference, the WWDC, in a new virtual format Monday.  The event highlighted Apple’s ongoing innovation efforts, and the company faces strong ecosystem benefits in the long-term, according to Baird. The Apple Analyst William Power...

With the COVID-19 pandemic clouding the outlook, consumer discretionary stocks such as Nike Inc (NYSE: NKE) face an uncertian future.  Nike is scheduled to release its fourth-quarter results Thursday, June 27 after the close. The Nike Analysts: Baird analyst Jonathan Komp maintained a Neutral...

Despite the skeptics, Tesla Inc (NASDAQ: TSLA) broke above the significant $1,000 price level for the first time in its history this month. The new high further accelerated the bullish optimism surrounding the company. Can Tesla stick the landing? “There continues to be a lot of...

Shares of Gilead Sciences, Inc. (NASDAQ: GILD) fell Thursday afternoon in reaction to a disappointing report on an early readout for its remdesivir therapy, but investors should not "give up on this drug," Baird analyst Brian Skorney said on CNBC's "Closing Bell." The...